drugset

drugset / Trial / NCT06904105

A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity

NCT06904105 ↗

Phase 3 Active not recruiting 556 enrolled Shandong Suncadia Medicine Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy and safety of HRS-7535 in subjects with overweight or obesity.

Timeline

Start: 2025-04-09
Primary completion: 2026-05
Completion: 2026-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-7535	Small molecule	—	—

Indications